SHJBF (Shanghai Junshi Biosciences Co) Quick Ratio: 1.38 (As of Dec. 2025) — 52% Below Median


SHJBF Shanghai Junshi Biosciences Co Ltd SHJBF
66 GF Score
Price $3.35
GF Value $5.63
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Quick Ratio?

Shanghai Junshi Biosciences Co SHJBF +11.67% 66 Quick Ratio is 1.38 as of Dec. 2025, which is 52% below its 10-year median of 2.89. GuruFocus rates SHJBF with a GF Score™ of 66/100 and a GF Value™ of $5.63 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,412 Biotechnology companies, Shanghai Junshi Biosciences Co ranks worse than 74.36% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Shanghai Junshi Biosciences Co's quick ratio for the quarter that ended in Dec. 2025 was 1.38.

Shanghai Junshi Biosciences Co has a quick ratio of 1.38. It generally indicates good short-term financial strength.

The historical rank and industry rank for Shanghai Junshi Biosciences Co's Quick Ratio or its related term are showing as below:

SHJBF' s Quick Ratio Range Over the Past 10 Years
Min: 1.38   Med: 2.89   Max: 28.36
Current: 1.38

During the past 10 years, Shanghai Junshi Biosciences Co's highest Quick Ratio was 28.36. The lowest was 1.38. And the median was 2.89.

SHJBF's Quick Ratio is ranked worse than
74.36% of 1412 companies
in the Biotechnology industry
Industry Median: 3.6 vs SHJBF: 1.38

Shanghai Junshi Biosciences Co  (OTCPK:SHJBF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Shanghai Junshi Biosciences Co Quick Ratio Related Terms


Shanghai Junshi Biosciences Co Quick Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co Quick Ratio Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.65 3.72 2.02 1.46 1.38

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.02 1.83 1.46 1.41 1.38

SHJBF vs VRTX, REGN, ALNY: Quick Ratio Comparison

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Junshi Biosciences Co Quick Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's Quick Ratio falls into.


SHJBF
66GF Score
Shanghai Junshi Biosciences Co Ltd SHJBF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Junshi Biosciences Co Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Shanghai Junshi Biosciences Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(632.909-81.371)/399.247
=1.38

Shanghai Junshi Biosciences Co's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(632.909-81.371)/399.247
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.38 mean?
Shanghai Junshi Biosciences Co (SHJBF) has a Quick Ratio of 1.38 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Junshi Biosciences Co and its competitors. This is 52% below median its historical median of 2.89. Over the past decade, Shanghai Junshi Biosciences Co's Quick Ratio has ranged from 1.38 to 28.36. According to the industry distribution chart, Shanghai Junshi Biosciences Co ranks #1050 out of 1412 companies in the Biotechnology industry, placing it in the top 74.4%.
Is Shanghai Junshi Biosciences Co's Quick Ratio too high?
Shanghai Junshi Biosciences Co's current Quick Ratio of 1.38 is 52% below median its 10-year median of 2.89. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 28.36. The Biotechnology industry median Quick Ratio is 3.60. Shanghai Junshi Biosciences Co's value of 1.38 is 61.7% below this industry median. Based on the distribution chart, Shanghai Junshi Biosciences Co ranks #1050 out of 1412 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Junshi Biosciences Co ranks #1050 out of 1412 companies for Quick Ratio. This places Shanghai Junshi Biosciences Co in the lower half of its industry. The industry median Quick Ratio is 3.60. Shanghai Junshi Biosciences Co's value of 1.38 is 61.7% below this benchmark. Historically, Shanghai Junshi Biosciences Co's own Quick Ratio has ranged from 1.38 to 28.36 over the past decade. While the company's 10-year median is 2.89 vs. the industry median of 3.60, Shanghai Junshi Biosciences Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Junshi Biosciences Co's current Quick Ratio of 1.38 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shanghai Junshi Biosciences Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Junshi Biosciences Co's current Quick Ratio is 1.38, which is 52% below median its own 10-year median of 2.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (SHJBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $5.63, compared to a current price of $3.35 — trading 40.5% below its estimated fair value. The current Quick Ratio is 1.38, which is 52% below median its 10-year median of 2.89 and 61.7% below the Biotechnology industry median of 3.60. Shanghai Junshi Biosciences Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current Quick Ratio is 1.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of $3.35 is trading 40.5% below its estimated GF Value™ of $5.63. GuruFocus considers Shanghai Junshi Biosciences Co to be Significantly Undervalued.

Key valuation signals for SHJBF:

  • Quick Ratio: 1.38 (52% below median its 10-year median of 2.89)
  • GF Value™: $5.63 vs. price of $3.35 (40.5% below fair value)
  • GF Score™: 66/100 with 5 warning signs
  • Industry Position: 61.7% below the Biotechnology median (#1050 of 1412)

No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Junshi Biosciences Co Business Description

Other Exchanges 01877:Hong Kong688180:China
Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
66GF Score

Get the complete analysis for SHJBF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$5.63
GF Value